arrow
Back
R

Ritesh R. Kotecha

Memorial Sloan Kettering Cancer Center

25H-index
221Paper Count
2.8KCitation Count
Published Papers 52
Publication Date
From diversity to function: microbiome precision in RCC
err2026-04-08
err0
PREAI
errAntonio Ocejo; Ritesh R. Kotecha; Martin H. Voss
errShare
errSave
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
errScience
IF45.8
err2026-02-26
err0
PREAI
errSophie A. Hanina; Tyler Park; Michael Lopez; Vinagolu K. Rajasekhar; Jorge Mansilla-Soto; Sascha Haubner; Huiyong Zhao; Friederike Kogel; Sarah Nataraj; Priyam Banerjee; Richard Koche; Pierre-Jacques Hamard; Zeynep C. Tarcan; Dennis S. Chi; Dmitriy Zamarin; John H. Healey; Elisa de Stanchina; Robert J. Motzer; Ritesh R. Kotecha; A. Ari Hakimi; Christina S. Leslie; Michel Sadelain
errShare
errSave
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone
err2025-12-01
err0
PREAI
errBarbakoff, Daniel; Dawidek, Mark T.; Knezevic, Andrea; Ganz, Marc; Posada, Lina; Khandwala, Yash; Sanmiguel, Andrea Lopez; Reese, Stephen W.; Oparanozie, Arnold; Liso, Nicole; Kotecha, Ritesh R.; Motzer, Robert J.; Reznik, Ed; Coleman, Jonathan; Ostrovnaya, Irina; Voss, Martin H.; Russo, Paul; Hakimi, A. Ari
errShare
errSave
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma
err2025-11-26
err0
PREAI
errYash S. Khandwala; Stephen W. Reese; Burcin A. Ucpinar; Andrea Knezevic; Lennert Eismann; Chih-Ying Wu; Rohan Mittal; Sahil Doshi; Daniel Barbakoff; Andrea Lopez Sanmiguel; Jonathan Coleman; Mark Dawidek; Robert J. Motzer; Paul Russo; Oguz Akin; Ritesh R. Kotecha; Ying-Bei Chen; Martin H. Voss; A. Ari Hakimi
errShare
errSave
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
err2025-11-14
err0
errOAAI
errTreg Grubb; Pooneh Koochaki; Sayed Matar; Fatme Ghandour; Marc Machaalani; Eddy Saad; Cerise Tang; Eduard Reznik; Jesminara Khatun; Carleigh Salem; Noah Dubasik; David A. Orlando; Matthew G. Guenther; Gyanu Parajuli; Raghvendra M. Srivastava; Steven R. Martinez; Jesse A. Coker; Ritesh R. Kotecha; A. Ari Hakimi; John M. Asara; Timothy A. Chan; Sakari Vanharanta; Shaun R. Stauffer; William G. Kaelin; Sabina Signoretti; Toni K. Choueiri; Abhishek A. Chakraborty
errShare
errSave
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma
err2025-11-04
err0
PREAI
errMark T. Dawidek; Lina Posada Calderon; Parantu K. Shah; Rohan Mittal; Burcin Agridag Ucpinar; Ziad Bakouny; Kevin Meli; Eddy Saad; Renée-Maria Saliby; H. Jun Woo; Yash S. Khandwala; Marc Eid; Chris Labaki; Marc Machaalani; Jonathan Coleman; Paul Russo; Ritesh R. Kotecha; Maria I. Carlo; Oguz Akin; David A. Braun; Toni K. Choueiri; Ed Reznik; Ying-Bei Chen; Robert J. Motzer; Martin H. Voss; A. Ari Hakimi
errShare
errSave
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma
err2025-11-01
err0
PREAI
errReese, Stephen W.; Barbakoff, Daniel; Ucpinar, Burcin Agridag; Knezevic, Andrea; Fitzgerald, Kelly; Eismann, Lennert; Tehrani, Yousef Mazaheri; Arroyave, Juan Sebastian; Khaleel, Sari; Khandwala, Yash S.; Dawidek, Mark; Motzer, Robert J.; Voss, Martin H.; Russo, Paul; Akin, Oguz; Kotecha, Ritesh R.; Hakimi, A. Ari
errShare
errSave
A Phase 1, multiple-dose study to evaluate the safety and tolerability of first-in-class XmAb819 (ENPP3 x CD3) in subjects with relapsed or refractory clear cell renal cell carcinoma (ccRCC) (NCT05433)
err2025-10-01
err0
errOAAI
errBohac, Chet; Pal, Sumanta; Sweis, Randy; Kotecha, Ritesh; Runcie, Karie; Bilen, Mehmet; Braun, David; Tykodi, Scott; Hoimes, Christopher; Suri, Vithika; Kanodia, Jitendra; Salama, Engie; Woo, Jacky; Li, Lingling; Yang, Yuanquan; Franklin, Robert; Maly, Joseph; Grigg, Claud; Gulati, Shuchi; Vanderweele, David J.; Garmezy, Benjamin
errShare
errSave
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
err2025-10-01
err0
errOAAI
errGrubb, Treg; Koochaki, Pooneh; Matar, Sayed; Ghandour, Fatme; Machaalani, Marc; Saad, Eddy; Tang, Cerise; Reznik, Eduard; Khatun, Jesminara; Salem, Carleigh; Dubasik, Noah; Orlando, David A.; Guenther, Matthew G.; Parajuli, Gyanu; Srivastava, Raghvendra M.; Martinez, Steven R.; Coker, Jesse; Kotecha, Ritesh; Hakimi, A. Ari; Asara, John; Chan, Timothy; Vanharanta, Sakari; Stauffer, Shaun; Kaelin, William G.; Signoretti, Sabina; Choueri, Toni; Chakraborty, Abhishek
errShare
errSave
Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma
err2025-10-01
err0
errOAAI
errVuong, Lynda; Cornish, Andrew; Khandwala, Yash; Jiang, Hui; Mascareno, Eduardo; Zheng, Doris; Rappold, Phillip; Leibold, Josef; Sabio, Erich; Weiss, Kate; Gonzalez, Carlene; Rittenhouse, Nicole; Ji, Liangliang; Zhang, Jing; Adlesic, Mojca; Akin, Oguz; Flynn, Jessica; Krishna, Chirag; Sanchez, Alejandro; Natale, Renzo Di; Blum, Kyle; Russo, Paul; Coleman, Jonathan; Frew, Ian; Chowell, Diego; Chen, Yingbei; Solit, David; Ostrovnaya, Irina; Motzer, Robert; Voss, Martin; Kotecha, Ritesh; Chan, Timothy; Kuo, Fengshen; Li, Ming; Hakimi, A. Ari
errShare
errSave
Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma☆
err2025-06-01
err0
errOAAI
errM. Sternschuss; N. Toumbacaris; J.P. Das; T. Powles; R.R. Kotecha; A.L. Laccetti; H. Xiao; E. Feld; D.J. McHugh; N.M. Keegan; D.F. Bajorin; S.A. Funt; N.J. Shah; G. Iyer; D.H. Aggen; M.Y. Teo; I. Ostrovnaya; J.E. Rosenberg
errShare
errSave
A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma
err2025-03-29
err0
PREAI
errRitesh R. Kotecha; Sahil D. Doshi; Andrea Knezevic; Rachel Jacobi; Hyung Jun Woo; David H. Aggen; Deaglan J. McHugh; Neil J. Shah; Maria I. Carlo; Niamh M. Keegan; Yogini Gayadin; Joshua Chaim; Mark T.A. Donoghue; Gopa Iyer; Chung-Han Lee; Darren R. Feldman; Robert J. Motzer; Martin H. Voss
errShare
errSave
Utilization and perceptions of chaplaincy among hospitalized adults of Dharmic religions with cancer
errCANCER
IF5.1
err2025-03-21
err0
errOAAI
errPatel, Rushil V.; Bowden, Jill M.; Boselli, Danielle; Strahley, Ashley E.; Gibbs, Sydney-Evelyn L.; Murali, Komal P.; Patel, Viraj R.; Kotecha, Ritesh R.; Nelson, Judith E.
errShare
errSave
Case report: Clinical and molecular features of renal gastrointestinal tumor
err2025-02-13
err0
errOAAI
errMakker, Simran; Rammal, Rayan; Gu, Ping; Dalbagni, Guido; Al-Ahmadie, Hikmat; Agaram, Narasimhan P.; Iyer, Gopa; Kotecha, Ritesh R.
errShare
errSave
Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma
err2025-02-04
err0
PREAI
errGed, Yasser; Touma, Amina; Contreras, Luis Meza; Elias, Roy; Van Galen, Joseph; Cupo, Olivia; Baraban, Ezra; Singla, Nirmish; Lee, Chung-Han; Pal, Sumanta; Zibelman, Matthew; Kotecha, Ritesh R.
errShare
errSave
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial (vol 86, pg 90, 2024)
err2025-01-01
err0
PREAI
errFitzgerald, Kelly N.; Lee, Chung-Han; Voss, Martin H.; Carlo, Maria I.; Knezevic, Andrea; Peralta, Laura; Chen, Yingbei; Lefkowitz, Robert A.; Shah, Neil J.; Owens, Colette N.; Mchugh, Deaglan J.; Aggen, David H.; Laccetti, Andrew L.; Kotecha, Ritesh R.; Feldman, Darren R.; Motzer, Robert J.
errShare
errSave
Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
err2024-09-01
err0
PREAI
errSternschuss, M.; Whiting, K.; Teo, M. Y.; Bajorin, D.; Kotecha, R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N.; Apollo, A.; Owens, C.; Funt, S. A.; Shah, N. J.; Iyer, G.; Aggen, D. H.; Ostrovnaya, I.; Rosenberg, J. E.
errShare
errSave
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial
err2024-08-01
err2
PREAI
errFitzgerald, Kelly N.; Lee, Chung-Han; Voss, Martin H.; Carlo, Maria I.; Knezevic, Andrea; Peralta, Laura; Chen, Yingbei; Lefkowitz, Robert A.; Shah, Neil J.; Owens, Colette N.; Mchugh, Deaglan J.; Aggen, David H.; Laccetti, Andrew L.; Kotecha, Ritesh R.; Feldman, Darren R.; Motzer, Robert J.
errShare
errSave
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
err2024-08-01
err1
PREAI
errKotecha, Ritesh R.; Doshi, Sahil D.; Knezevic, Andrea; Chaim, Joshua; Chen, Yingbei; Jacobi, Rachel; Zucker, Mark; Reznik, Ed; McHugh, Deaglan; Shah, Neil J.; Feld, Emily; Aggen, David H.; Rafelson, William; Xiao, Han; Carlo, Maria I.; Feldman, Darren R.; Lee, Chung-Han; Motzer, Robert J.; Voss, Martin H.
errShare
errSave
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery
err2024-08-01
err0
PREAI
errJennifer Ma; Luke del Balzo; Henry Walch; Sari Khaleel; Andrea Knezevic; Jessica Flynn; Zhigang Zhang; Jordan Eichholz; Sahil D. Doshi; Martin H. Voss; Benjamin Freeman; A. Ari Hakimi; Chung-Han Lee; Tejus A. Bale; Daniel Kelly; Boris A. Mueller; Justin Mann; Yao Yu; Melissa Zinovoy; Linda Chen; John Cuaron; Atif Khan; Yoshiya Yamada; Jacob Y. Shin; Kathryn Beal; Nelson S. Moss; Maria I. Carlo; Robert J. Motzer; Brandon S. Imber; Ritesh R. Kotecha; Luke R.G. Pike
errShare
errSave